NDC 62584-713-11 - Allopurinol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62584-713
- Requested NDC
- 62584-713-11
- Package NDCs from labels
- 62584-713-11, 62584-713-01
- Manufacturer
- American Health Packaging
- Effective date
- 2022-12-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Allopurinol - American Health Packaging | American Health Packaging | 2022-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62584-713-01 | EA - Each | 62584-713 | 24452d87-7d89-435e-8aff-eadbe921e4eb | 1 | 2012-07-24 |
| 62584-713-11 | EA - Each | 62584-713 | 5770382c-3ecc-488b-831f-0bd1385d4a59 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ALLOPURINOL | ACTIVE INGREDIENT | 63CZ7GJN5I | ALLOPURINOL TABLET [AMERICAN HEALTH PACKAGING] | 4 | |
| ALLOPURINOL | ACTIVE MOIETY | 63CZ7GJN5I | ALLOPURINOL TABLET [AMERICAN HEALTH PACKAGING] | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ALLOPURINOL TABLET [AMERICAN HEALTH PACKAGING] | 4 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ALLOPURINOL TABLET [AMERICAN HEALTH PACKAGING] | 4 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | ALLOPURINOL TABLET [AMERICAN HEALTH PACKAGING] | 4 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ALLOPURINOL TABLET [AMERICAN HEALTH PACKAGING] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALLOPURINOL TABLET [AMERICAN HEALTH PACKAGING] | 4 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | ALLOPURINOL TABLET [AMERICAN HEALTH PACKAGING] | 4 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ALLOPURINOL TABLET [AMERICAN HEALTH PACKAGING] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allopurinol | ALLOPURINOL | REMEDYREPACK INC. | 8f50e91e-66a7-4fd4-888a-9f1986aa661c | 2026-09-10 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Dr. Reddy's Laboratories Limited | 19a138b8-d225-03e6-f762-abe71560204b | 2026-09-03 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | REMEDYREPACK INC. | 4dbced9a-ef6f-455e-8d5d-b635409521db | 2026-09-03 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | REMEDYREPACK INC. | 165f2ebb-a099-4d31-b21a-93b341c39429 | 2026-08-27 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | REMEDYREPACK INC. | 36526c80-5a70-47c4-a0a6-785ccc346703 | 2026-08-14 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | REMEDYREPACK INC. | 5ffcbc32-5996-41cd-acdc-cc4af8cdaf4f | 2026-08-14 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | PD-Rx Pharmaceuticals, Inc. | f1c11f74-1de2-484c-b40b-d0013e8fd01a | 2026-08-07 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | PD-Rx Pharmaceuticals, Inc. | f130c9c0-45d8-42bc-a040-04bb077671f8 | 2026-08-07 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | PD-Rx Pharmaceuticals, Inc. | b2ab2389-ccaf-487b-9985-50e3539e7617 | 2026-08-07 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | PD-Rx Pharmaceuticals, Inc. | 211e47c6-85b9-43e8-9e07-6cc4b8f708a0 | 2026-08-07 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| ALLOPURINOL | ALLOPURINOL | Aphena Pharma Solutions - Tennessee, LLC | 583df4b8-a1d4-01ed-e063-6394a90af007 | 2026-08-04 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Sun Pharmaceutical Industries, Inc. | fd8f8b8b-f25e-46e9-969a-65363b66e09b | 2026-07-31 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Cardinal Health 107, LLC | ced59048-c147-4702-af32-2f9b517ed87a | 2026-07-24 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Cardinal Health 107, LLC | b6c5b5c0-b1cb-44c0-a849-5d317e6fa300 | 2026-07-21 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | REMEDYREPACK INC. | 55280a8a-cf23-405b-b698-95a4d8e3c699 | 2026-07-14 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 6341a72d-9c83-448c-871b-e800ad8f1547 | 2026-07-13 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| ALLOPURINOL | ALLOPURINOL | Aphena Pharma Solutions - Tennessee, LLC | 5644814c-3f61-5338-e063-6294a90ad6c9 | 2026-07-10 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Major Pharmaceuticals | 8c0f5af5-a453-4641-933f-ccb2625fca39 | 2026-06-24 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 156d743c-6324-44db-9230-21f762d64cfd | 2026-06-11 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | b943dbb1-7f54-434c-9439-8ce768d94ff4 | 2026-06-10 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.